| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/24/2009 | US20090241220 Nucleic Acid Molecules and Other Molecules Associated with Plants |
| 09/24/2009 | US20090241219 Gdc-2 genes conferring herbicide resistance |
| 09/24/2009 | US20090241218 Plants having enhanced yield-related traits and a method for making the same |
| 09/24/2009 | US20090241217 Yield-improved transgenic plants |
| 09/24/2009 | US20090241215 Use of armadillo repeat (arm1) polynucleotides for obtaining pathogen resistance in plants |
| 09/24/2009 | US20090241213 Cotton variety 565452g |
| 09/24/2009 | US20090241212 Cotton variety 468300g |
| 09/24/2009 | US20090241211 Cotton variety 303308g |
| 09/24/2009 | US20090241210 Cotton variety 779020g |
| 09/24/2009 | US20090241209 High lycopene content tomato plants and markers for use in breeding for same |
| 09/24/2009 | US20090241208 Improving cold resistance of transgenic plants with nucleic acids encoding cold tolerance-modulating polypeptides |
| 09/24/2009 | US20090241207 Expression of heterologous genes according to a targeted expression profile |
| 09/24/2009 | US20090241206 Methods for cloning ferrets and transgenic ferret models for diseases |
| 09/24/2009 | US20090241204 Animal model comprising in its genome a homozygous disruption of an endogenous mouse multidrug-resistance-1 (MDR-1) gene ; drug screening; pharmacokinetics and pharmacodynamics; predicting likely behaviour of a drug in mouse |
| 09/24/2009 | US20090241203 Transgenic animal models of disease |
| 09/24/2009 | US20090241202 Domain-grafted antibodies |
| 09/24/2009 | US20090240073 Method for detoxifying phosphonate herbicides |
| 09/24/2009 | US20090240044 Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography |
| 09/24/2009 | US20090240043 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 09/24/2009 | US20090240039 Polypeptide fusion |
| 09/24/2009 | US20090239939 Combinations for introducing nucleic acids into cells |
| 09/24/2009 | US20090239934 Anti-Myosin Va siRNA and Skin Depigmentation |
| 09/24/2009 | US20090239932 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 09/24/2009 | US20090239916 Novel drug discovery target and medicine acting on the same |
| 09/24/2009 | US20090239908 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 09/24/2009 | US20090239837 Cholesterol-producing yeast strains and uses thereof |
| 09/24/2009 | US20090239816 Multitargeting Interfering RNAs And Methods Of Their Use And Design |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239797 Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses |
| 09/24/2009 | US20090239795 exendin-4 fused to a transferrin (Tf) via a polypeptide linker; for treatment of Type II diabetes, obesity, and to reduce body weight |
| 09/24/2009 | US20090239794 Hcv f protein and uses thereof |
| 09/24/2009 | US20090239793 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 09/24/2009 | US20090239790 Novel recombinant proteins with n-terminal free thiol |
| 09/24/2009 | US20090239759 Multiplexed molecular analysis systems |
| 09/24/2009 | US20090239305 Gene recombination exchange system for stable gene modification in human ES cells |
| 09/24/2009 | US20090239297 Avian cell lines useful for the production of substrates of interest |
| 09/24/2009 | US20090239285 Tandem reapeat dna constructs producing proteins that attack plant pathogenic viruses, fungi, and bacteria by disrupting transcription factors essential for replication thereof in plants |
| 09/24/2009 | US20090239284 Used for production of malto-oligosaccharides with a DP of less than 10, and as a detergent enzyme; a preference for soluble substrates, shows substantial exo-amylase activity and has a pH optimum of about 9.8 |
| 09/24/2009 | US20090239277 Thermophillic Organisms For Conversion Of Lignocellulosic Biomass To Ethanol |
| 09/24/2009 | US20090239276 Genetically modified yeast strain |
| 09/24/2009 | US20090239272 set of genes which encodes for enzymes which can convert substrates belonging to the general category of phenylpropanoids and result in the production of flavanones; without the need for chemical conversion |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090239264 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 09/24/2009 | US20090239263 Expression Control Using Antibody Expression Optimisation Sequences |
| 09/24/2009 | US20090239262 Affinity Polypeptide for Purification of Recombinant Proteins |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090239260 Fungal Transcriptional Activator Useful In Methods for Producing Polypeptides |
| 09/24/2009 | US20090239259 Mammalian expression vectors and uses thereof |
| 09/24/2009 | US20090239258 comprising the nucleotide sequence of SEQ ID NO:98 and/or the nucleotide sequence of SEQ ID NO:100; for diagnosing at least one IL-6 related condition in a cell, tissue, organ, animal or patient |
| 09/24/2009 | US20090239249 Novel thermostable gluconate dehydratase and use thereof |
| 09/24/2009 | US20090239240 Mutant Forms of Fas Ligand and Uses Thereof |
| 09/24/2009 | US20090239239 Eukaryotic amadoriase having excellent thermal stability, gene and recombinant dna for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability |
| 09/24/2009 | US20090239237 METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM |
| 09/24/2009 | US20090239227 Method of diagnosing risk of myocardial infarction |
| 09/24/2009 | US20090239220 Dlc-1 gene deleted in cancers |
| 09/24/2009 | US20090239219 Telomerase expression repressor proteins and methods of using the same |
| 09/24/2009 | US20090239216 Novel Tannase Gene And Protein Thereof |
| 09/24/2009 | US20090239211 Method For Enrichment Involving Elimination By Mismatch Hybridisation |
| 09/24/2009 | US20090238945 Soybean Cultivar 7113111 |
| 09/24/2009 | US20090238923 Variants of bacillus licheniformis alpha-amylase with increased thermostability and/or decreased calcium dependence |
| 09/24/2009 | US20090238922 Proteases |
| 09/24/2009 | US20090238921 Mutant strains of lactic acid bacteria having a non-phosphorylable lactose permease |
| 09/24/2009 | US20090238862 Methods and Compositions for Seprase Inactivation |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |
| 09/24/2009 | US20090238825 Novel rabbit antibody humanization methods and humanized rabbit antibodies |
| 09/24/2009 | US20090238823 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 09/24/2009 | US20090238822 Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response |
| 09/24/2009 | US20090238821 Humanized antibodies that sequester amyloid beta peptide |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |
| 09/24/2009 | US20090238804 Use of cells containing a specific dna molecule as cytopathic agents to inhibit the proliferation of cells |
| 09/24/2009 | US20090238798 Nucleotide Sequences Encoding Insecticidal Proteins |
| 09/24/2009 | US20090238795 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/24/2009 | US20090238791 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15beta/gamma, and hyperagonist (il-15ralpha sushi - il-15) fusion proteins |
| 09/24/2009 | US20090238789 Modified erythropoietin polypeptides and uses thereof |
| 09/24/2009 | CA2753758A1 Floral dip method for transformation of camelina |
| 09/24/2009 | CA2718961A1 Enhancing vessel lesion homing and repair potential of stem cells |
| 09/24/2009 | CA2718946A1 Non-competitive internal controls for use in nucleic acid tests |
| 09/24/2009 | CA2718905A1 Expression-linked gene discovery |
| 09/24/2009 | CA2718904A1 Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
| 09/24/2009 | CA2718887A1 Genetic analysis |
| 09/24/2009 | CA2718868A1 Polynucleotides and chimaera polypeptides for releasing a polypeptide of interest combined with exosomes and use thereof for the production of immunogenic compositions |
| 09/24/2009 | CA2718708A1 Genetic indicators of weight loss |
| 09/24/2009 | CA2718706A1 Partial peptide of lacritin |
| 09/24/2009 | CA2718429A1 Nrps-pks gene cluster and its manipulation and utility |
| 09/24/2009 | CA2718269A1 Container for receiving and storing biological material, especially dna |
| 09/24/2009 | CA2718011A1 Compositions and methods for analysis of nucleic acid molecules during amplification reaction using footprint probes |
| 09/24/2009 | CA2715737A1 Polypeptide having glyoxalase iii activity, polynucleotide encoding the same and uses thereof |
| 09/24/2009 | CA2713884A1 Crystalline structure of the cc2-lz domain of nemo |
| 09/24/2009 | CA2712705A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2103690A1 Method for modifying insect resistance of plants by utilizing rnai technique |
| 09/23/2009 | EP2103689A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2103688A2 Method for modifying plant morphology, biochemistry and physiology |
| 09/23/2009 | EP2103685A1 Vectors and methods for generating vector-free induced pluripotent stem (iPS) cells using site-specific recombination |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP2103629A1 Gamma -1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 09/23/2009 | EP2103628A1 Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same |
| 09/23/2009 | EP2102366A2 Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi |